Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104962488 | 10496248 | 8 | F | 2008 | 20160705 | 20141003 | 20160714 | EXP | PT-JNJFOC-20140915547 | JOHNSON AND JOHNSON | ALMEIDA JP, LOPES A, BARBOSA MP. HYPERSENSITIVITY TO PROTON PUMP INHIBITORS ?] A RARE CASE. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA 2013;21 (5):44. ALMEIDA JP, LOPES A, BARBOSA MP. HYPERSENSITIVITY TO PROTON PUMP INHIBITORS - A RARE CASE. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2014;69:347. ALMEIDA JP, LOPES A, BARBOSA MP. HYPERSENSITIVITY TO PROTON PUMP INHIBITOR - A RARE CASE REPORT. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA 2016;24 (1):31-36. | 35.00 | YR | A | F | Y | 0.00000 | 20160714 | MD | PT | PT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104962488 | 10496248 | 1 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | Y | U | 0 | 400 | MG | UNSPECIFIED | ||||||
104962488 | 10496248 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | Y | U | 0 | UNSPECIFIED | ||||||||
104962488 | 10496248 | 3 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | Y | U | 17463 | UNSPECIFIED | ||||||||
104962488 | 10496248 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 5 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | 4 | MG | UNSPECIFIED | |||||||
104962488 | 10496248 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | 20 | MG | UNSPECIFIED | |||||||
104962488 | 10496248 | 7 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 8 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 9 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 10 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | 20 | MG | UNSPECIFIED | |||||||
104962488 | 10496248 | 11 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | 4 | MG | UNSPECIFIED | |||||||
104962488 | 10496248 | 12 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 13 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 14 | SS | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 15 | SS | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | U | 0 | UNSPECIFIED | ||||||||||
104962488 | 10496248 | 16 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Intravenous (not otherwise specified) | U | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 17 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Intravenous (not otherwise specified) | U | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 18 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 19 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | U | 0 | UNSPECIFIED | |||||||||
104962488 | 10496248 | 20 | C | DESLORATADINE. | DESLORATADINE | 1 | 0 | 5 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104962488 | 10496248 | 1 | Influenza like illness |
104962488 | 10496248 | 2 | Influenza like illness |
104962488 | 10496248 | 3 | Influenza like illness |
104962488 | 10496248 | 4 | Influenza like illness |
104962488 | 10496248 | 5 | Influenza like illness |
104962488 | 10496248 | 6 | Influenza like illness |
104962488 | 10496248 | 7 | Influenza like illness |
104962488 | 10496248 | 8 | Influenza like illness |
104962488 | 10496248 | 9 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 10 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 11 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 12 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 13 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 14 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 15 | Product used for unknown indication |
104962488 | 10496248 | 16 | Product used for unknown indication |
104962488 | 10496248 | 17 | Product used for unknown indication |
104962488 | 10496248 | 18 | Gastrooesophageal reflux disease |
104962488 | 10496248 | 19 | Product used for unknown indication |
104962488 | 10496248 | 20 | Rhinitis allergic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104962488 | 10496248 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104962488 | 10496248 | Angioedema | |
104962488 | 10496248 | Drug hypersensitivity | |
104962488 | 10496248 | Generalised erythema | |
104962488 | 10496248 | Pruritus | |
104962488 | 10496248 | Type IV hypersensitivity reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104962488 | 10496248 | 1 | 2008 | 0 | ||
104962488 | 10496248 | 4 | 2007 | 0 | ||
104962488 | 10496248 | 5 | 2008 | 0 | ||
104962488 | 10496248 | 6 | 2008 | 0 | ||
104962488 | 10496248 | 7 | 2010 | 0 | ||
104962488 | 10496248 | 9 | 2010 | 0 | ||
104962488 | 10496248 | 10 | 2008 | 0 | ||
104962488 | 10496248 | 11 | 2008 | 0 | ||
104962488 | 10496248 | 12 | 2007 | 0 | ||
104962488 | 10496248 | 17 | 2007 | 0 | ||
104962488 | 10496248 | 19 | 2007 | 0 |